日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Healthy Lifestyle Interventions for Non-communicable Disease Prevention in Saudi Arabia: A Scoping Review

沙特阿拉伯非传染性疾病预防的健康生活方式干预措施：范围界定综述

期刊:Cureus Journal of Medical Science
影响因子:1.3
doi:10.7759/cureus.99800
Alhumaid, Alla; Alotaibi, Abdulaziz; Tayeb, Mashael; Alqhatani, Yousef; Walbi, Ibrahim
发表日期：2025
文献求助 收藏

Nanoengineered chitosan functionalized titanium dioxide biohybrids for bacterial infections and cancer therapy

纳米工程壳聚糖功能化二氧化钛生物混合物用于细菌感染和癌症治疗

期刊:Scientific Reports
影响因子:3.8
doi:10.1038/s41598-024-52847-1
Mohammad Shabib Akhtar, Karthikeyan Chandrasekaran, Sharmila Saminathan, Siva Ranjani Rajalingam, Nehal Mohsin, Khalid Altigani Awad Alkarem Ahmed, Yasir Alhazmi, Ismail A Walbi, Basel A Abdel-Wahab, Amol D Gholap, Md Faiyazuddin, Gowri Sundaram
肿瘤
发表日期：2024
文献求助 收藏

Status of diabetes mellitus in different regions of KSA and update on its management

沙特阿拉伯不同地区糖尿病现状及其管理进展

期刊:Frontiers in Clinical Diabetes and Healthcare
影响因子:2.2
doi:10.3389/fcdhc.2024.1482090
Al-Rasheedi, Mabrouk; Alhazmi, Yasir; AlDaiji, Lamees Abdullah; AlDaiji, Lamya Abdullah; Mobarki, Fatimah Ismail; Almuhaysini, Khuzama Mohammed; Alshammari, Jawza Salem; Almistadi, Nouf Awadh; Yoldash, Saeed Adnan; Almaqwashi, Nouf; Al Abdulgader, Rawabi Saleh; Mashyakhi, Mohammed Yahya; Alamro, Sadin; Walbi, Ismail A; Haider, Khawaja Husnain
糖尿病
代谢
发表日期：2024
文献求助 收藏

Predicting Hydroxychloroquine Clearance in Healthy and Diseased Populations Using a Physiologically Based Pharmacokinetic Approach

利用基于生理药代动力学的方法预测健康人群和患病人群中羟氯喹的清除率

期刊:Pharmaceutics
影响因子:5.5
doi:10.3390/pharmaceutics15041250
Alqahtani, Faleh; Asiri, Ali Mohammed; Zamir, Ammara; Rasool, Muhammad Fawad; Alali, Amer S; Alsanea, Sary; Walbi, Ismail A
发表日期：2023
文献求助 收藏

Recent Progress in Chitosan-Based Nanomedicine for Its Ocular Application in Glaucoma

壳聚糖基纳米药物在青光眼眼科应用中的最新进展

期刊:Pharmaceutics
影响因子:5.5
doi:10.3390/pharmaceutics15020681
Albarqi, Hassan A; Garg, Anuj; Ahmad, Mohammad Zaki; Alqahtani, Abdulsalam A; Walbi, Ismail A; Ahmad, Javed
神经科学
青光眼
发表日期：2023
文献求助 收藏

The relationship between hydroxychloroquine plasma concentration and COVID-19 outcomes in rheumatoid arthritis patients in Saudi Arabia

沙特阿拉伯类风湿关节炎患者血浆羟氯喹浓度与新冠肺炎预后的关系

期刊:Saudi Pharmaceutical Journal
影响因子:3
doi:10.1016/j.jsps.2022.05.006
Ismail A Walbi, Hussain Alqhtani, Faleh Alqahtani, Saad Ahmed Alkahtani, Ali Mohamed Alshabi, Amer S Alali, Hassan A Albarqi
免疫
关节炎
新冠
肺炎
发表日期：2022
文献求助 收藏

Physicochemical Characterization of Chitosan-Decorated Finasteride Solid Lipid Nanoparticles for Skin Drug Delivery

用于皮肤药物输送的壳聚糖修饰非那雄胺固体脂质纳米粒的物理化学表征

期刊:Biomed Research International
影响因子:2.6
doi:10.1155/2022/7792180
Muhammad Sohaib, Shefaat Ullah Shah, Kifayat Ullah Shah, Kifayat Ullah Shah, Nauman Rahim Khan, Malik Muhammad Irfan, Zahid Rasul Niazi, Abdulsalam A Alqahtani, Ali Alasiri, Ismail A Walbi, Sajid Mahmood
表观遗传
发表日期：2022
文献求助 收藏

Effect of chronic hydroxychloroquine use on COVID-19 risk in patients with rheumatoid arthritis and systemic lupus erythematosus: a multicenter retrospective cohort

长期服用羟氯喹对类风湿性关节炎和系统性红斑狼疮患者感染 COVID-19 风险的影响：一项多中心回顾性队列研究

期刊:Journal of International Medical Research
影响因子:1.5
doi:10.1177/03000605221090363
Walbi, Ismail A; Albarqi, Hassan A; Alghanim, Nayef Saleh; Albadi, Marzooq Abdullah; Al Maimouni, Hesham Mohammed; Alkahtani, Saad Ahmed; Alshabi, Ali Mohamed; Alali, Amer S; Alqahtani, Faleh; Al-Najjar, Amal Hassan; Hazzazi, Mohammad A; Alanazi, Deemah S; Sabei, Abdulrahman Abdulaziz; Alsaweed, Omer S; Alajra, Rahaf K; Alqhtani, Hussain
炎症/感染
关节炎
红斑狼疮
免疫/内分泌
发表日期：2022
文献求助 收藏

Exploitation of Design-of-Experiment Approach for Design and Optimization of Fast-Disintegrating Tablets for Sublingual Delivery of Sildenafil Citrate with Enhanced Bioavailability Using Fluid-Bed Granulation Technique

利用实验设计方法，采用流化床制粒技术设计并优化用于舌下给药的速崩西地那非柠檬酸盐片剂，以提高其生物利用度。

期刊:Pharmaceutics
影响因子:5.5
doi:10.3390/pharmaceutics13060870
AlAli, Amer S; Aldawsari, Mohammed F; Alalaiwe, Ahmed; Almutairy, Bjad K; Al-Shdefat, Ramadan; Walbi, Ismail A; Fayed, Mohamed H
发表日期：2021
文献求助 收藏

A Phase 1 Study of the PARP Inhibitor Veliparib in Combination with Temozolomide in Acute Myeloid Leukemia.

PARP抑制剂Veliparib联合替莫唑胺治疗急性髓系白血病的I期研究

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-16-0984
Gojo Ivana, Beumer Jan H, Pratz Keith W, McDevitt Michael A, Baer Maria R, Blackford Amanda L, Smith B Douglas, Gore Steven D, Carraway Hetty E, Showel Margaret M, Levis Mark J, Dezern Amy E, Gladstone Douglas E, Ji Jiuping Jay, Wang Lihua, Kinders Robert J, Pouquet Marie, Ali-Walbi Ismail, Rudek Michelle A, Poh Weijie, Herman James G, Karnitz Larry M, Kaufmann Scott H, Chen Alice, Karp Judith E
肿瘤
白血病
肿瘤免疫
发表日期：2017
文献求助 收藏